Analysts forecast that Cotiviti Holdings Inc (NYSE:COTV) will announce $190.21 million in sales for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Cotiviti’s earnings, with the lowest sales estimate coming in at $188.11 million and the highest estimate coming in at $193.10 million. Cotiviti posted sales of $174.19 million during the same quarter last year, which would indicate a positive year over year growth rate of 9.2%. The business is scheduled to issue its next quarterly earnings report on Tuesday, October 30th.

According to Zacks, analysts expect that Cotiviti will report full year sales of $767.31 million for the current fiscal year, with estimates ranging from $745.07 million to $796.80 million. For the next year, analysts forecast that the company will post sales of $821.64 million per share, with estimates ranging from $808.60 million to $835.30 million. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that cover Cotiviti.

Cotiviti (NYSE:COTV) last released its quarterly earnings results on Thursday, July 26th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.45 by $0.01. The company had revenue of $176.85 million during the quarter, compared to the consensus estimate of $183.38 million. Cotiviti had a net margin of 21.49% and a return on equity of 12.44%. Cotiviti’s revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.38 earnings per share.

COTV has been the topic of a number of recent analyst reports. TheStreet upgraded shares of Cotiviti from a “c” rating to a “b-” rating in a report on Friday, May 25th. Robert W. Baird cut shares of Cotiviti from an “outperform” rating to a “neutral” rating and set a $24.00 price target on the stock. in a report on Tuesday, June 19th. SunTrust Banks cut shares of Cotiviti from a “buy” rating to a “hold” rating and set a $24.00 price target on the stock. in a report on Tuesday, June 19th. Mitsubishi UFJ Financial Group cut shares of Cotiviti from an “overweight” rating to a “neutral” rating in a report on Tuesday, June 19th. Finally, William Blair cut shares of Cotiviti from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 19th. Two equities research analysts have rated the stock with a sell rating and eleven have assigned a hold rating to the stock. Cotiviti presently has a consensus rating of “Hold” and a consensus price target of $36.07.

In other Cotiviti news, COO David Beaulieu sold 5,000 shares of Cotiviti stock in a transaction on Friday, May 18th. The shares were sold at an average price of $35.00, for a total value of $175,000.00. Following the completion of the transaction, the chief operating officer now directly owns 44,425 shares of the company’s stock, valued at approximately $1,554,875. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Jonathan Olefson sold 20,000 shares of Cotiviti stock in a transaction on Tuesday, June 19th. The stock was sold at an average price of $41.10, for a total transaction of $822,000.00. Following the completion of the transaction, the senior vice president now directly owns 20,884 shares of the company’s stock, valued at $858,332.40. The disclosure for this sale can be found here. Over the last quarter, insiders sold 121,800 shares of company stock worth $4,543,550. 7.50% of the stock is currently owned by insiders.

Large investors have recently modified their holdings of the business. Trexquant Investment LP bought a new stake in Cotiviti during the 1st quarter valued at about $424,000. Envestnet Asset Management Inc. raised its holdings in shares of Cotiviti by 31.5% in the 1st quarter. Envestnet Asset Management Inc. now owns 29,488 shares of the business services provider’s stock valued at $1,016,000 after purchasing an additional 7,070 shares in the last quarter. Chicago Capital LLC bought a new stake in shares of Cotiviti in the 1st quarter valued at about $7,402,000. JPMorgan Chase & Co. raised its holdings in shares of Cotiviti by 3.1% in the 1st quarter. JPMorgan Chase & Co. now owns 2,194,905 shares of the business services provider’s stock valued at $75,592,000 after purchasing an additional 66,877 shares in the last quarter. Finally, Citadel Advisors LLC raised its holdings in shares of Cotiviti by 28.8% in the 1st quarter. Citadel Advisors LLC now owns 52,322 shares of the business services provider’s stock valued at $1,802,000 after purchasing an additional 11,687 shares in the last quarter. 91.52% of the stock is owned by institutional investors and hedge funds.

COTV traded up $0.05 during midday trading on Tuesday, reaching $44.66. The company’s stock had a trading volume of 342,788 shares, compared to its average volume of 390,143. The stock has a market cap of $4.18 billion, a PE ratio of 29.74, a price-to-earnings-growth ratio of 2.09 and a beta of 0.52. The company has a debt-to-equity ratio of 0.61, a quick ratio of 3.41 and a current ratio of 3.41. Cotiviti has a 1 year low of $30.84 and a 1 year high of $44.76.

About Cotiviti

Cotiviti Holdings, Inc, through its subsidiaries, provides analytics-driven payment accuracy and spend management solutions primarily for the healthcare sector in the United States, Canada, the United Kingdom, and India. It operates through two segments, Healthcare, and Global Retail and Other. The company offers prospective claims accuracy solutions that enable healthcare clients identify and address claim discrepancies immediately following claim adjudication and before a claim is paid to a healthcare provider; and retrospective claims accuracy solutions that enable health insurers identify and resolve payment inaccuracies after a claim has been paid to a healthcare provider.

Featured Article: Growth Stocks

Get a free copy of the Zacks research report on Cotiviti (COTV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cotiviti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotiviti and related companies with MarketBeat.com's FREE daily email newsletter.